Tag Archives: John Mantsch

Company founded by two Marquette University researchers raises $26 million in funding

News release, April 10, 2017

Promentis Pharmaceuticals, a Milwaukee company co-founded by Drs. John Mantsch and David Baker, researchers from the Marquette University College of Health Sciences, raised $26 million, including $17.2 million in its third funding round. OrbiMed, F-Prime Capital Partners (formerly Fidelity Biosciences) and Aisling Capital were the lead investors. This is exceptional syndicate of investors, particularly for […]

Continue...

Marquette researchers receive $1.85 million grant for neuroscience study

News release, September 11, 2014

Research will examine novel mechanism contributing to addiction A group of neuroscientists in the College of Health Sciences at Marquette University has been awarded a $1.85 million National Institutes of Health grant to examine a novel neurotransmitter clearance mechanism that may hold a key to understanding the link between stress and drug addiction, as well […]

Continue...

Marquette researcher receives $2.6 million grant to fund brain studies

News release, June 24, 2014

Research study will examine stress-induced relapse in cocaine addiction Dr. John Mantsch, professor and chair of biomedical sciences in Marquette University’s College of Health Sciences, has been awarded a $2.6 million grant from the National Institutes of Health that will fund research on the effects of stress in drug addiction relapse. “Despite decades of research, […]

Continue...